Biopharma | April 14, 2026
Gennova CEO Dr Sanjay Singh sees strong innovation momentum for India’s biopharma sector
Veteran biopharma leader stressed that generic medicines must be viewed separately from biologics
Veteran biopharma leader stressed that generic medicines must be viewed separately from biologics
This event will bring together global stakeholders to explore India’s growing capabilities in pharma and biopharma innovation, research, and manufacturing
The two-day conference and exhibition features discussions on policy frameworks, AI-led drug discovery, next-generation technologies, and global competitiveness
Nature Medicine study delivers strongest real-world evidence yet for India’s indigenous rotavirus vaccine under UIP
Discussions are likely to centre on how the country can move up the pharmaceutical value chain
The data will be presented at the 2026 European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global Congress in Munich, April 17-21
The collaboration promises expanded funding for Thai universities, research institutes, companies, and global research partners working in Thailand
New filtration lines will boost global drug supply and strengthen India’s role in Merck’s manufacturing network
In his new role, Saran will spearhead the end-to-end launch framework for innovation-led portfolio
He brings extensive cross-functional expertise built through leadership roles
Subscribe To Our Newsletter & Stay Updated
